Nantahala Capital Management - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 66 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q2 2023$10,167,843
-28.2%
4,272,203
-44.5%
0.98%
-9.3%
Q1 2023$14,152,936
-4.3%
7,691,813
-1.2%
1.08%
+13.2%
Q4 2022$14,785,834
+30.7%
7,782,018
+47.2%
0.96%
+30.9%
Q3 2022$11,312,000
-22.3%
5,286,088
+2.8%
0.73%
+0.3%
Q2 2022$14,554,000
-19.7%
5,142,855
+18.3%
0.73%
-9.0%
Q1 2022$18,124,000
-14.4%
4,346,327
+6.6%
0.80%
+7.7%
Q4 2021$21,162,000
+10.0%
4,077,509
+38.8%
0.74%
+22.9%
Q3 2021$19,236,000
+61.5%
2,936,791
+63.7%
0.61%
+79.3%
Q2 2021$11,909,0001,793,5000.34%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q3 2022
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 21,346,829$49,738,11274.10%
TFG Asset Management GP Ltd 12,000,000$27,960,0005.10%
Paradigm Biocapital Advisors LP 14,406,782$33,567,8022.28%
Lynx1 Capital Management LP 1,363,025$3,175,8482.10%
Deep Track Capital, LP 15,000,000$34,950,0001.35%
Affinity Asset Advisors, LLC 1,992,466$4,642,4461.31%
DAFNA Capital Management LLC 928,253$2,162,8290.67%
Frazier Life Sciences Management, L.P. 3,746,857$8,730,1770.58%
ARMISTICE CAPITAL, LLC 6,900,000$16,077,0000.25%
Blackstone Inc. 20,485,611$47,731,4740.20%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders